May 13 |
Tyra Biosciences (NASDAQ:TYRA) Is In A Good Position To Deliver On Growth Plans
|
May 10 |
Tyra Biosciences GAAP EPS of -$0.35 beats by $0.11
|
May 9 |
Tyra Biosciences Reports First Quarter 2024 Financial Results and Highlights
|
May 7 |
Tyra Biosciences Announces Appointments of Susan Moran, M.D., M.S.C.E. and S. Michael Rothenberg, M.D., Ph.D. to its Board of Directors
|
Mar 20 |
Tyra Biosciences Inc (TYRA) Reports Increased R&D Investments Amid Pipeline Progress
|
Mar 19 |
Tyra Biosciences GAAP EPS of -$0.53 misses by $0.05
|
Mar 19 |
Tyra Biosciences files to sell 15.37M shares of common stock for holders
|
Mar 19 |
Tyra Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights
|
Mar 6 |
Insider Sell: Tyra Biosciences Inc (TYRA) COO Daniel Bensen Sells 9,152 Shares
|
Mar 1 |
Insider Sell: Tyra Biosciences Inc (TYRA) COO Daniel Bensen Sells 8,644 Shares
|